research Androgenetic alopecia; drug safety and therapeutic strategies
Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.
Search
for
Sort by
Research
390-420 / 569 results 
research The psychosocial burden of androgenetic alopecia in Saudi Arabia: A cross-sectional study
Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.
research 42003 Hormonal profile of androgenetic alopecia in adolescents and its association with metabolic dysfunction: single center retrospective study
Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.
research Patterned Alopecia (Androgenic Alopecia)
Hair loss can be caused by hormones and genetics.
research Serum Gelsolin Levels in PCOS-Related Androgenetic Alopecia
Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.
research Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review
Low vitamin D levels are linked to hair loss, and vitamin D might help treat it.
research COVID ‐19 induced telogen effluvium
COVID-19 may cause temporary hair loss in some people.
research Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.
research Androgenic Alopecia in a Patient with Systemic Lupus Erythematosus
A new minoxidil regimen improved hair loss in a lupus patient.
research Introductory Chapter: Alopecia Management – An Update
Some types of hair loss can be reversed, others are permanent, and treatments vary by type.
research Role of iron in telogen effluvium among premenopausal women
Iron deficiency may contribute to chronic hair loss in premenopausal women.
research Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
Different types of persistent hair loss after chemotherapy respond differently to treatments.
research Comparative evaluation of two Unani formulation combinations in the treatment of Telogen Effluvium: A randomized, single-blind clinical trial
Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.
research Tissue and serum levels of substance P in trichodynia of androgenetic alopecia patients
Higher substance P levels may cause discomfort in hair loss patients.
research Primary cicatricial alopecia associated with systemic indolent mastocytosis
Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.
research Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.
research Study of the international epidemiology of androgenetic alopecia in young caucasian men using photographs from the internet
15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.
research Concurrent Lichen Planopilaris and Female Androgenic Alopecia in Skin of Color: A Case Series.
Thorough scalp exams are crucial for diagnosing hair loss conditions in people with skin of color.
research Androgenic Alopecia: Recent Understanding of the Androgenetic Receptor-Mediated Molecular Mechanisms and Current Pharmacotherapy
Androgenic alopecia is mainly caused by DHT, and new treatments focus on hair regeneration and aging factors.
research Dermatological perspectives on pressure alopecias: A call for awareness
Increased awareness and research are needed to prevent hair loss from cosmetic procedures.
research Positioning of low alcohol or alcohol-free minoxidil formulation for the management of androgenetic alopecia: Indian perspective
Alcohol-free minoxidil is better for treating hair loss in Indian men.
research Telogen Effluvium: A Review of the Literature
The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.
research Referee report. For: Pathogenesis of Androgenetic alopecia [v1; indexed, http://f1000r.es/5ar]
Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.
research Central centrifugal cicatricial alopecia in Black men: A case series highlighting key clinical features in this cohort
The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.
research Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients
Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.
research Revisión actualizada del tratamiento de la alopecia androgenética femenina
Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.
research Genetic and molecular aspects of androgenetic alopecia
Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.
research Telogen Effluvium: Is There a Need for a New Classification
The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.
research Evaluating Testosterone and Dehydroepiandrosterone Sulfate (DHEA-S) as Biomarkers for Male Androgenetic Alopecia
Higher testosterone and DHEA-S levels may be linked to male pattern baldness.
research Management of Telogen Effluvium: A Survey among Dermatologists and Dermatology Residents of Nepal
A standardized guideline would improve Telogen Effluvium management.